- Category
- Micro (2024-25)
- Udyam number
- UDYAM-AP-17-0009045

Elevar Life Sciences Private Limited
About Elevar Life Sciences Private Limited
Data last updated:
Elevar Life Sciences Private Limited is a private limited company based in Kakinada, Andhra Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24299AP2021PTC119621. Its GSTIN is 37AAGCE6844H1ZD (Andhra Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹50,000. It is led by directors Hari Krishna Saladi (Managing Director) and Sri Satya Subha Akash Velumuri.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D.No 1 – 14 – 18 Sri Ram Nagar Revenue Ward No 1, Kakinada, Andhra Pradesh, India – 533003.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.16 Lakh, a decline of 52% compared to the previous year. For the same year it recorded a net loss of ₹11.3 Lakh (net margin -69.9%) and EBITDA of -₹11.3 Lakh (EBITDA margin -69.9%).
Elevar Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-17-0009045).
Company details
Recognitions & Rankings of Elevar Life Sciences
Contact details
Elevar Life Sciences Private Limited's registered office is in Kakinada, Andhra Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD.No 1 – 14 – 18 Sri Ram Nagar Revenue Ward No 1, Kakinada, Andhra Pradesh, India – 533003
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Elevar Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Elevar Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Elevar Life Sciences Private Limited, buy the company report.
Financials of Elevar Life Sciences Private Limited
FY 2024 filings availableElevar Life Sciences Private Limited reported revenue of ₹16.16 Lakh (down 52% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 52% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹11.3 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹11.3 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -69.9% | ||
| Net Profit Margin | -69.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Elevar Life Sciences Private Limited, buy the company report.
Board of directors of Elevar Life Sciences Private Limited
Elevar Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hari Krishna Saladi | Managing Director | 04 Oct 2021 | 5 Years 1 Months | Current |
| Sri Satya Subha Akash Velumuri | Director | 04 Oct 2021 | 5 Years 1 Months | Current |
Auditor
Elevar Life Sciences Private Limited is audited by Brahmananda Reddy & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Brahmananda Reddy & Associates | FY 2023 | 016662S |
Shareholding
The shareholding of Elevar Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Elevar Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Elevar Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elevar Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Elevar Life Sciences Private Limited has 1 active EPFO establishment as of Mar 30, 2024.
GST
Elevar Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAGCE6844H1ZD | Andhra Pradesh | Active | 13 Oct 2021 |
To see the full GST registrations and return filing status of Elevar Life Sciences Private Limited, buy the company report.
Recent activity
Elevar Life Sciences Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Hari Krishna Saladi was appointed as Managing Director on 04 Oct 2021.
Frequently asked questions
Elevar Life Sciences is an active private limited company based in Kakinada, Andhra Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 October 2021 (5+ years old) and is registered under CIN U24299AP2021PTC119621.
Elevar Life Sciences has 2 current directors:
- Hari Krishna Saladi - Managing Director
- Sri Satya Subha Akash Velumuri - Director
The latest financial statements of Elevar Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Elevar Life Sciences is 37AAGCE6844H1ZD, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Elevar Life Sciences is U24299AP2021PTC119621. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elevar Life Sciences was incorporated on 04 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Vijayawada.
Hari Krishna Saladi was appointed as Managing Director on 04 Oct 2021. Sri Satya Subha Akash Velumuri was appointed as Director on 04 Oct 2021.
Yes, Elevar Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-17-0009045).
The registered office of Elevar Life Sciences is at D.No 1 – 14 – 18 Sri Ram Nagar Revenue Ward No 1, Kakinada, Andhra Pradesh, India – 533003.
Elevar Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

